The recognition and treatment of autoimmune epilepsy in children (Q38284599)

1 September 2017

1 reference

title

The recognition and treatment of autoimmune epilepsy in children (English)

1 reference

1 September 2017

Jehan Suleiman

1

1 reference

PubMed ID

25483277

1 September 2017

Russell C Dale

series ordinal

2

1 reference

1 September 2017

8 December 2014

1 reference

Developmental Medicine and Child Neurology

1 September 2017

1 reference

1 September 2017

57

1 reference

1 September 2017

5

1 reference

1 September 2017

431-440

1 reference

The role of inflammation in epilepsy

1 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

Seizure-induced brain-borne inflammation sustains seizure recurrence and blood-brain barrier damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

The role of cytokines in the pathophysiology of epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

Potassium channel antibodies in two patients with reversible limbic encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

Paraneoplastic limbic encephalitis: clinico-pathological correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

Rasmussen's encephalitis: clinical features, pathobiology, and treatment advances.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

NMDA receptor antibody encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

Paediatric autoimmune encephalopathies: clinical features, laboratory investigations and outcomes in patients with or without antibodies to known central nervous system autoantigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

N-methyl-D-aspartate receptor antibodies in pediatric dyskinetic encephalitis lethargica

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

Autoimmune epilepsy in children: case series and proposed guidelines for identification

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

Aggressive course in encephalitis with opsoclonus, ataxia, chorea, and seizures: the first pediatric case of γ-aminobutyric acid type B receptor autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

VGKC antibodies in pediatric encephalitis presenting with status epilepticus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

Autoimmune epilepsy: clinical characteristics and response to immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

The detection of neural autoantibodies in patients with antiepileptic-drug-resistant epilepsy predicts response to immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

Systemic and neurologic autoimmune disorders associated with seizures or epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

Autoantibodies to neuronal surface antigens in thyroid antibody-positive and -negative limbic encephalitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

CSF albumin and immunoglobulin analyses in childhood neurologic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

Clinical association of intrathecal and mirrored oligoclonal bands in paediatric neurology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

Cerebrospinal fluid neopterin in paediatric neurology: a marker of active central nervous system inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

Cerebrospinal fluid and serum cytokine profiling to detect immune control of infectious and inflammatory neurological and psychiatric diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

Neuronal voltage-gated potassium channel complex autoimmunity in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

Limbic encephalitis in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

Cortical hypometabolism demonstrated by PET in relapsing NMDA receptor encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

FDG-PET hyperactivity in basal ganglia correlating with clinical course in anti-NDMA-R antibodies encephalitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

Acute mechanisms underlying antibody effects in anti-N-methyl-D-aspartate receptor encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

Elevated VGKC-complex antibodies in a boy with fever-induced refractory epileptic encephalopathy in school-age children (FIRES).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

Extreme delta brush: a unique EEG pattern in adults with anti-NMDA receptor encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

Early electro-clinical features may contribute to diagnosis of the anti-NMDA receptor encephalitis in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

Limbic encephalitis: a cause of temporal lobe epilepsy with onset in adult life

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

Autoantibodies to neuronal antigens in children with new-onset seizures classified according to the revised ILAE organization of seizures and epilepsies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

GABA(B) receptor antibodies in limbic encephalitis and anti-GAD-associated neurologic disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

Encephalitis and GABAB receptor antibodies: novel findings in a new case series of 20 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

Glycine receptor autoimmune spectrum with stiff-man syndrome phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

Progressive encephalomyelitis, rigidity, and myoclonus: a novel glycine receptor antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

Progressive encephalomyelitis with rigidity and myoclonus: the first pediatric case with glycine receptor antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

Glycine receptor antibodies in a boy with focal epilepsy and episodic behavioral disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

Anti-glutamic Acid decarboxylase antibody associated limbic encephalitis in a child: expanding the spectrum of pediatric inflammatory brain diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

Limbic encephalitis associated with anti-GAD antibody and common variable immune deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

Cell-surface central nervous system autoantibodies: clinical relevance and emerging paradigms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

Antibodies to surface dopamine-2 receptor and N-methyl-D-aspartate receptor in the first episode of acute psychosis in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

In vivo effects of antibodies from patients with anti-NMDA receptor encephalitis: further evidence of synaptic glutamatergic dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

Disrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

Human limbic encephalitis serum enhances hippocampal mossy fiber-CA3 pyramidal cell synaptic transmission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

Myasthenia gravis and neuromyelitis optica spectrum disorder: a multicenter study of 16 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

Utility of an immunotherapy trial in evaluating patients with presumed autoimmune epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

Effect of rituximab in patients with leucine-rich, glioma-inactivated 1 antibody-associated encephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

Central nervous system neuronal surface antibody associated syndromes: review and guidelines for recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

Neuronal autoantigens--pathogenesis, associated disorders and antibody testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

Population-level evidence for an autoimmune etiology of epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

Caspr2 antibody limbic encephalitis is associated with Hashimoto thyroiditis and thymoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

Investigation of neuronal autoantibodies in two different focal epilepsy syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

Morvan's syndrome associated with voltage-gated K+ channel antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

An effective immunotherapy regimen for VGKC antibody-positive limbic encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

Successful treatment of two paediatric cases of anti-NMDA receptor encephalitis with cyclophosphamide: the need for early aggressive immunotherapy in tumour negative paediatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12647

21 January 2018

Identifiers

DOI

10.1111/DMCN.12647

1 reference

1 September 2017

1 reference

PubMed ID

25483277